Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Antiarthritic profile of BF-389--a novel anti-inflammatory agent with low ulcerogenic liability.

Wong S, Lee SJ, Frierson MR 3rd, Proch J, Miskowski TA, Rigby BS, Schmolka SJ, Naismith RW, Kreutzer DC, Lindquist R.

Agents Actions. 1992 Sep;37(1-2):90-8.

PMID:
1456184
2.

Correlation of anti-inflammatory activity with peak tissue rather than peak plasma levels of BF389.

Bendele AM, Ruterbories KJ, Spaethe SM, Benslay DN, Lindstrom TD, Lee SJ, Naismith RW.

J Pharmacol Exp Ther. 1992 Mar;260(3):1194-8.

PMID:
1545387
3.

Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.

Bendele AM, Benslay DN, Hom JT, Spaethe SM, Ruterbories KJ, Lindstrom TD, Lee SJ, Naismith RW.

J Pharmacol Exp Ther. 1992 Jan;260(1):300-5.

PMID:
1309875
4.
5.

Variations on the standard protocol design of the hepatocyte DNA repair assay.

Barfknecht TR, Naismith RW, Kornbrust DJ.

Cell Biol Toxicol. 1987 Jun;3(2):193-207.

PMID:
3507255

Supplemental Content

Loading ...
Support Center